PerOs Overview

  • Year Founded
  • 2000

Year Founded

  • Status
  • Out of Business

  • Employees
  • 4

Employees

  • Latest Deal Type
  • Out of Business

PerOs General Information

Description

Developer of oral bioactive delivery platform designed to brings together a composite of biologically active ingredients that can neutralize the gastric enzymes. The company's bioactive delivery platform has developed non-encapsulation strategies to provide oral administration of bioactive compounds like vaccines, peptides, and antibodies for various animals, such as fish, shrimp, swine, poultry, and companion animals, enabling users control diseases and secure the food safety.

Contact Information

Website
www.perosbio.com
Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Corporate Office
  • 788 Méthot Boulevard
  • Saint-Nicolas, Quebec G7A 3W4
  • Canada
+1 (418)
Primary Industry
Biotechnology
Other Industries
Other Pharmaceuticals and Biotechnology
Drug Delivery
Vertical(s)
Life Sciences
Corporate Office
  • 788 Méthot Boulevard
  • Saint-Nicolas, Quebec G7A 3W4
  • Canada
+1 (418)

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

PerOs Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Out of Business 01-Sep-2011 Completed Out of Business
2. Later Stage VC (Series C) 10-May-2004 Completed Startup
1. Early Stage VC (Series B) 27-Nov-2002 $1.6M $1.6M Completed Startup
To view PerOs’s complete valuation and funding history, request access »

PerOs Patents

  • 9

    Total Documents Applications and Grants

  • Total Patents Families

  • 1

    Granted

  • 1

    Pending

  • Expiring in next 12 mo

PerOs Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2003218576-A1 Composition for modulating a physiological reaction or inducing an immune response Inactive 08-Apr-2002
US-20050175724-A1 Composition for modulating at least one physiological reaction or inducing an immune response in human or animal after oral administration; for intestinal delivery of a physiologically active agent, a neutralizing agent, an inhibitor of digestive enzymes, an uptake increasing agent; synergistic Inactive 08-Apr-2002
CA-2481752-A1 Composition for modulating a physiological reaction or inducing an immune response Inactive 08-Apr-2002
EP-1494542-A1 Composition for modulating a physiological reaction or inducing an immune response Inactive 08-Apr-2002
JP-2005522203-A Composition for modulating physiological response or inducing immune response Pending 08-Apr-2002 A61K9/0095
To view PerOs’s complete patent history, request access »

PerOs Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Ready to get started?

Request a free trial

PerOs FAQs

  • When was PerOs founded?

    PerOs was founded in 2000.

  • Where is PerOs headquartered?

    PerOs is headquartered in Saint-Nicolas, Canada.

  • What is the size of PerOs?

    PerOs has 4 total employees.

  • What industry is PerOs in?

    PerOs’s primary industry is Biotechnology.

  • Is PerOs a private or public company?

    PerOs is a Private company.

  • What is PerOs’s current revenue?

    The current revenue for PerOs is .

  • How much funding has PerOs raised over time?

    PerOs has raised $9.6M.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »